Metraipolis › archive › dc_501f9067cfa8
Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers — Europe PMC PMID:42406230
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42406230
- DOI
- 10.1186/s43046-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T11:08:41.072Z
- SHA-256 of the archived text
e0ea10d16cbcd3aa5e059675f267a03f36bd01abc9905e6ef001067531077955- Stable URL of this page
https://metraipolis.com/documento/dc_501f9067cfa8
How to cite
Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers — Europe PMC PMID:42406230 — Europe PMC (en), https://europepmc.org/article/MED/42406230 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_501f9067cfa8 (Metraipolis archive dc_501f9067cfa8, sha256 e0ea10d16cbcd3aa5e059675f267a03f36bd01abc9905e6ef001067531077955)
BibTeX
@misc{dc501f9067cfa8,
title = {Immune checkpoint inhibitors in advanced cholangiocarcinoma: a systematic review of efficacy, safety, and emerging biomarkers — Europe PMC PMID:42406230},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42406230},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_501f9067cfa8; sha256 e0ea10d16cbcd3aa5e059675f267a03f36bd01abc9905e6ef001067531077955},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42406230. Agents can read the archived copy with the MCP tool read_document.